These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27093396)

  • 1. [Not Available].
    Sauer M; Degen O; Beyersdorff D
    Rofo; 2016 Aug; 188(8):782-3. PubMed ID: 27093396
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rare, but significant complication after BCG instillation therapy after urothelial carcinoma].
    Stahl T; Engelhardt F; Layer G
    Rofo; 2013 Dec; 185(12):1199-200. PubMed ID: 23832635
    [No Abstract]   [Full Text] [Related]  

  • 3. [BCGitis].
    Husain-Syed F; Velcovsky HG
    Dtsch Med Wochenschr; 2006 Apr; 131(16):877-8. PubMed ID: 16625480
    [No Abstract]   [Full Text] [Related]  

  • 4. Tuberculous epididymo-orchitis after intravesical BCG therapy for superficial bladder carcinoma: sonographic findings.
    Salvador R; Vilana R; Bargalló X; Araque X; Nicolau C
    J Ultrasound Med; 2007 May; 26(5):671-4. PubMed ID: 17460010
    [No Abstract]   [Full Text] [Related]  

  • 5. [BCG therapy. Its role in the treatment of tumors of the bladder].
    Patard JJ; Chopin DK; Abbou CC
    Ann Urol (Paris); 1995; 29(5):292-3. PubMed ID: 8638911
    [No Abstract]   [Full Text] [Related]  

  • 6. Microbladder after the BCG therapy.
    Ballestero Diego R; Zubillaga Guerrero S; García-Barón PL; Truán Cacho D; Portillo Martín JA; del Valle Schaan JI; Correas Gómez MÁ; Hidalgo Zabala E; Campos Juanatey F; Gala Solana L; Mediavilla Díez E; Fuentes Pastor J
    Arch Esp Urol; 2014 Sep; 67(7):657-8. PubMed ID: 25436263
    [No Abstract]   [Full Text] [Related]  

  • 7. [Abdominal and retroperitoneal abscesses in a patient with bladder carcinoma receiving BCG therapy].
    Fernández JM; Cartón JA; Rodríguez A; Asensi V
    Enferm Infecc Microbiol Clin; 2009 Oct; 27(8):485-6. PubMed ID: 19406520
    [No Abstract]   [Full Text] [Related]  

  • 8. [ BCG-immunotherapy and bladder cancer].
    Rischmann P
    Prog Urol; 2008 May; 18 Suppl 5():S93. PubMed ID: 18585633
    [No Abstract]   [Full Text] [Related]  

  • 9. Strategies for optimizing bacillus Calmette-Guérin.
    Shah JB; Kamat AM
    Urol Clin North Am; 2013 May; 40(2):211-8. PubMed ID: 23540779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure squamous cell carcinoma after intravesical BCG treatment. A case report.
    Yurdakul T; Avunduk MC; Piskin MM
    Urol Int; 2005; 74(3):283-5. PubMed ID: 15812221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic BCG reactions after intravesical BCG therapy. A report of four cases].
    Sfaxi M; Langar H; Ouni A; Riahi Y; El Aidli S; Daghfous R; Ben Abdeladhim A; Chébil M
    Therapie; 2008; 63(1):43-7. PubMed ID: 18387275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCG installations for bladder cancer and latent tuberculosis infection.
    Hanson K
    Urol Nurs; 2002 Apr; 22(2):132-4. PubMed ID: 11993243
    [No Abstract]   [Full Text] [Related]  

  • 13. Ocular involvement following Bacillus Calmette-Guerin immunotherapy for bladder carcinoma.
    Cugati S; Gilhotra JS; Lake S; Gordon DL
    Clin Exp Ophthalmol; 2014 Jul; 42(5):494-5. PubMed ID: 24372891
    [No Abstract]   [Full Text] [Related]  

  • 14. Worsening of bullous pemphigoid following bacillus Calmette-Guérin treatment for bladder cancer.
    Johnson JL; West DA; Travers JB
    JAMA Dermatol; 2013 Feb; 149(2):248-9. PubMed ID: 23426500
    [No Abstract]   [Full Text] [Related]  

  • 15. [Disseminated infection due to Mycobacterium bovis alter intravesical instillation of BCG].
    de la Iglesia Fanjul I; de Castro Losa MR; Mourad F; Bajo Franco T
    An Med Interna; 2007 Oct; 24(10):514-5. PubMed ID: 18333323
    [No Abstract]   [Full Text] [Related]  

  • 16. Miliary tuberculosis after intravesical bacille Calmette-Guérin immunotherapy for carcinoma of the bladder.
    Rabe J; Neff KW; Lehmann KJ; Mechtersheimer U; Georgi M
    AJR Am J Roentgenol; 1999 Mar; 172(3):748-50. PubMed ID: 10063874
    [No Abstract]   [Full Text] [Related]  

  • 17. Miliary tuberculosis of the lung in a patient treated with bacillus Calmette-Guerin for superficial bladder cancer.
    Iantorno R; Nicolai M; Storto ML; Ciccotosto C; Cipollone G; Mastroprimiano G; Tenaglia RL
    J Urol; 1998 May; 159(5):1639-40. PubMed ID: 9554372
    [No Abstract]   [Full Text] [Related]  

  • 18. What is the optimal BCG dose in non-muscle-invasive bladder cancer?
    Witjes JA
    Eur Urol; 2007 Nov; 52(5):1300-2. PubMed ID: 17531374
    [No Abstract]   [Full Text] [Related]  

  • 19. An unusual cause of retention of urine after intravesical Bacillus Calmette-Guérin therapy for superficial bladder cancer.
    Cheung JM; Hou SS; Yip SK; Ng CF
    Hong Kong Med J; 2011 Dec; 17(6):492-4. PubMed ID: 22147321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Imaging findings in BCGitis--Bacillus-Calmette-Guérin-Infektion (BCGitis) after intravesical BCG instillation therapy in urothelial carcinoma of the urinary bladder].
    Kaufmann S; Amend B; Kruck S; Gakis G; Bedke J; Horger M
    Rofo; 2015 Aug; 187(8):623-7. PubMed ID: 26218471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.